Lymphoma (Subscribe)
Links
Adult Hodgkins Lymphoma Treatment NCI
Adult Hodgkin's Lymphoma (PDQ®): Treatment
More than 75% of all newly diagnosed patients with adult Hodgkin’s lymphoma (HL) can be cured with combination chemotherapy and/or radiation therapy. National mortality has fallen more rapidly for adult HL than for any other malignancy. Prognosis for a given patient depends on several factors. The most important factors are the presence or absence of systemic symptoms, the stage of disease, presence of large masses, and the quality and suitability of the treatment administered. Other important factors are age (therapy for very young children requires special attention), sex, erythrocyte sedimentation rate, extent of abdominal involvement, hematocrit, and absolute number of nodal sites of involvement
More than 75% of all newly diagnosed patients with adult Hodgkin’s lymphoma (HL) can be cured with combination chemotherapy and/or radiation therapy. National mortality has fallen more rapidly for adult HL than for any other malignancy. Prognosis for a given patient depends on several factors. The most important factors are the presence or absence of systemic symptoms, the stage of disease, presence of large masses, and the quality and suitability of the treatment administered. Other important factors are age (therapy for very young children requires special attention), sex, erythrocyte sedimentation rate, extent of abdominal involvement, hematocrit, and absolute number of nodal sites of involvement
Adult Non-Hodgkins Lymphoma
Adult Non-Hodgkin's Lymphoma (PDQ®): Treatment
The NHLs are a heterogeneous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment.[2] Like Hodgkin’s lymphoma, NHL usually originates in lymphoid tissues and can spread to other organs. NHL, however, is much less predictable than Hodgkin’s lymphoma and has a far greater predilection to disseminate to extranodal sites. The prognosis depends on the histologic type, stage, and treatment.
The NHLs are a heterogeneous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment.[2] Like Hodgkin’s lymphoma, NHL usually originates in lymphoid tissues and can spread to other organs. NHL, however, is much less predictable than Hodgkin’s lymphoma and has a far greater predilection to disseminate to extranodal sites. The prognosis depends on the histologic type, stage, and treatment.
Childhood Hodgkin Lymphoma PDQ
Childhood Hodgkin Lymphoma (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, treatment, and potential late therapy effects of childhood Hodgkin lymphoma.
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, treatment, and potential late therapy effects of childhood Hodgkin lymphoma.
Childhood Non-Hodgkin Lymphoma PDQ
Childhood Non-Hodgkin Lymphoma (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, and treatment of childhood non-Hodgkin lymphoma (NHL).
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, and treatment of childhood non-Hodgkin lymphoma (NHL).
Lymphoma Doctors Doctor
Lymphomas are broadly divided into Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. They are malignant proliferations of cells which are normally found in lymphoid organs such as lymph nodes, tonsils, spleen, and thymus gland. In addition, lymphomas may arise in every other type of organ such as the brain or stomach, and these are termed extra-nodal lymphomas. One of the most exciting areas of research has focused on the role of viruses as the cause of two types of lymphoma. The HTLV-1 virus, a retrovirus similar to HIV, has been definitely implicated in the pathogenesis of the rare Adult T cell leukemia/lymphoma. The Epstein-Barr virus, the agent that causes infectious mononucleosis, has been implicated in Burkitt's lymphoma. Over the years, classification systems have evolved from purely morphologic systems combined with prognostic categories (Working Classification) to classification systems which integrate immunohistochemical data (REAL and WHO Classifications)
Malignant Lymphoma eMedicine Orthopedics
Primary lymphoma of bone is an uncommon disease and must be separated from skeletal involvement in systemic lymphoma. The former is stage IE (extranodal, see Staging) disease and may present to the orthopedic surgeon prior to biopsy as a solitary bone lesion simulating a bone sarcoma. The latter, by definition, is stage IV disease and is usually not initially seen by the orthopedic surgeon except when a patient is being treated for complications of systemic lymphoma, such as pathologic fracture.
See also the following related articles in eMedicine:
Hodgkin Disease [in the Hematology section]
Hodgkin Disease [in the Pediatrics: General Medicine section]
Lymphoma, B-Cell
Lymphoma, Diffuse Large Cell
Lymphoma, Malignant Anaplastic (Ki 1+)
Lymphoma, Mantle Cell
Lymphoma, Non-Hodgkin
Lymphoma, Bone
Synonyms and related keywords: osteolymphoma, reticulum cell sarcoma, primary lymphoma of bone, bone cancer, Paget disease, bone lymphoma, bone pain
Mathur & Damron 2008
Synonyms and related keywords: osteolymphoma, reticulum cell sarcoma, primary lymphoma of bone, bone cancer, Paget disease, bone lymphoma, bone pain
Mathur & Damron 2008
Reticulum Cell Sarcoma SA Registrars Notebook
Brief Notes - Incidence, Clinical, Xrays, Pathology, Investigations, Differential Dx, Treatment, Prognosis
Reticulum Cell Sarcoma Wheeless
Discussion:
- bone tumor derived from reticuloendothelial elements of marrow;
- it presents in middle age;
- causes localized bone pain w/ tenderness & effussion in adjacent joints
